News|Articles|April 2, 2004
- Pharmaceutical Technology-04-02-2004
- Volume 28
- Issue 4
Controlled-Release Dosage Forms for Diltiazem Hydrochloride
Author(s)Ramesh Panchagnula, PhD
The authors investigate whether an extrusion-spheronization proces can be used to develop a matrix-based, controlled-release formulation for a highly water-soluble drug.
Advertisement
Articles in this issue
over 22 years ago
Spotlight on Business Riskover 22 years ago
Vibration Technology for Active Dry-Powder Inhalersover 22 years ago
In the Spotlight April 2004over 22 years ago
FDA Attacks Counterfeitsover 22 years ago
Synthetic Excipients Challenge All-Natural Organicsover 22 years ago
April 2004Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The FDA Moves to Modernize Drug Manufacturing Registration
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
4
Overcoming Raw-Material Variability Challenges for Autologous Adoptive Cell Therapies
5